Unexpectedly, even though RTN4 plays a role in two major pathomechanisms underlying MS (i.e., axonal degeneration and demyelination), it seemingly has less diagnostic significance in the disease than NfL, particularly at disease onset. The gene discussed is RTN4; the disease is myeloid sarcoma.